Active, not recruitingPhase 2NCT06303570

A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas

Studying Adiposis dolorosa

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Caliway Biopharmaceuticals Co., Ltd.
Intervention: CBL-514 injection(drug)
Enrollment: 19 enrolled
Eligibility: 18-64 years · All sexes
Timeline: 2024 – 2026

Study locations (1)

Investigator Site, Spokane, Washington, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06303570 on ClinicalTrials.gov

Other trials for Adiposis dolorosa

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONNCT00833599
Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
The University of Texas Health Science Center, Houston

See all trials for Adiposis dolorosa →

← Back to all trials